KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Change in Acquisitions & Divestments (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with -$18.3 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 245.77% to -$18.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.9 million through Sep 2025, up 258.01% year-over-year, with the annual reading at $19.8 million for FY2024, 1274.03% up from the prior year.
  • Change in Acquisitions & Divestments hit -$18.3 million in Q4 2025 for Royalty Pharma, down from $2.9 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $853.1 million in Q2 2021 to a low of -$243.4 million in Q2 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $126.9 million across 5 years, with a median of $12.6 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 1657.49% in 2022 and later crashed 245.77% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $104.7 million in 2021, then rose by 10.43% to $115.6 million in 2022, then tumbled by 98.75% to $1.4 million in 2023, then soared by 774.03% to $12.6 million in 2024, then plummeted by 245.77% to -$18.3 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for RPRX at -$18.3 million in Q4 2025, $2.9 million in Q3 2025, and $2.9 million in Q2 2025.